Rankings / Sleep & Recovery

Glucosamine + chondroitin

Sleep & Recovery · Joint matrix substrate

Tier B-

anti-inflammatoryotc
6.3 / 10
Tier B-
Ev 4 Bn 3.5 Sf 10

Bottom line

Read Off Label grades Glucosamine + chondroitin as B- (6.3/10) based on mixed evidence, low-moderate benefit magnitude, and a very low-risk safety profile.

Long-debated supplement.

Typical use: 1500 mg glucosamine sulfate + 1200 mg chondroitin sulfate daily; sulfate forms (not HCl) preferred per OARSI — OTC.

What this is

Long-debated supplement. Cochrane and OARSI both shifted to 'against' or 'conditional' over time, citing weak effect sizes. Bell BMJ 2020 cohort (n=466,039) found 15-21% reduction in CV mortality with regular use — has revived interest. Reasonable choice for knee OA where cost is low and downside is minimal. Emphasize sulfate form and Rotta-Pharma-style standardized products in Europe — quality varies widely.

Mechanism

Endogenous glycosaminoglycans / proteoglycan precursors; oral supplementation of the building blocks for cartilage extracellular matrix; weak anti-inflammatory effects; long-term users show reduced cartilage volume loss in some MRI studies

Dose & route

1500 mg glucosamine sulfate + 1200 mg chondroitin sulfate daily; sulfate forms (not HCl) preferred per OARSI

Common questions

Does Glucosamine + chondroitin work?
Read Off Label rates the evidence for Glucosamine + chondroitin as Mixed and the benefit magnitude as low-moderate, producing an overall grade of B- (6.3/10). Long-debated supplement.
Is Glucosamine + chondroitin safe?
Glucosamine + chondroitin has a very low risk profile in published human data. Legal status: OTC. This is not medical advice — see the disclaimer.
What is the typical dose for Glucosamine + chondroitin?
1500 mg glucosamine sulfate + 1200 mg chondroitin sulfate daily; sulfate forms (not HCl) preferred per OARSI
How does Glucosamine + chondroitin work?
Endogenous glycosaminoglycans / proteoglycan precursors; oral supplementation of the building blocks for cartilage extracellular matrix; weak anti-inflammatory effects; long-term users show reduced cartilage volume loss in some MRI studies

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.